Background Treatment options for patients with ankylosing spondylitis are few. We aimed to
assess the effectiveness of infliximab, an antibody to tumour necrosis factor (TNF)-α, in …

… [13] Adamitzki W; Glowa G, Laugel N, Loeser C, Nestler K, Zeidler H. Research and
applications of an electrochemical surface treatment for metallic workpieces by means of aqueous …

Classification criteria for most of the disorders belonging to the spondylarthropathy group
already exist. However, the spectrum of spondylarthropathy is wider than the sum of these …

… Zeidler has received consulting fees and/or honoraria of less than $10,000 from Pfizer, Inc.
… Zeidler has received consulting fees and/or honoraria of less than $10,000 from Pfizer, Inc. …

Objective Ankylosing spondylitis (AS) is diagnosed late, because radiographs of the sacroiliac
joints often do not show definite sacroiliitis at the time of disease onset. The aim of this …

An increase in geriatric population coupled by a growing incidence of different vascular
ailments including peripheral vascular and coronary artery diseases imply that the medical …

… ZEIDLER et aI … Zeidler H: Undifferentiated arthritis and spondylarthropathy as a major
problem of diagnosis and classification. Scand JRheumatol Suppl 65:54-62, 1987 84. …

… More ulcers were detected in patients positive for H pylori than in those negative for H
pylori in the two groups (table 3). Corticosteroid use had no effect on the number of ulcers that …

Objective: To develop evidence-based recommendations for the management of systemic
glucocorticoid (GC) therapy in rheumatic diseases. Methods: The multidisciplinary guideline …

Objective To assess prospectively the rates and to explore predictors of spinal radiographic
progression over 2 years in a cohort of patients with early axial spondylarthritis (SpA). …